Live Cell Encapsulation Market

BioTime, Inc. (US) and Reed Pacific Pty Ltd. (Australia) are leading players in Live Cell Encapsulation Market

The global live cell encapsulation market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Factors such as the increasing incidence of target diseases, rising adoption of novel drug delivery systems for disease treatment, technology advancements, increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management are driving the growth of the live cell encapsulation market. However, high manufacturing costs, the limited availability of high-quality raw materials, and the significant adoption of alternative therapies are expected to restrain the growth of this market during the forecast period.

The major players operating in the live cell encapsulation market include BioTime, Inc. (US), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (US), Neurotech Pharmaceuticals, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top five players in the global live cell encapsulation market. Other prominent players operating in this market are Merck KGAA (Germany), Sigilon Therapeutics, Inc. (US), Encapsys, LLC (US), Evonik Industries (Germany), Lycored (Israel), MiKroCaps (Slovenia), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), Sernova Corporation (Canada), and Balchem Corporation (US), among others. The analysis of market developments between 2014 and 2018 revealed that several growth strategies such as research collaborations and strategic market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the live cell encapsulation market.

To know about the assumptions considered for the study download the pdf brochure

BioTime, Inc. (US) dominated the live cell encapsulation market in 2017. The company has a strong geographic presence across the regions such as US, Australia, New Zealand, Israel, Canada, China, Japan, and Taiwan. BioTime, Inc. mainly focuses on product commercialization to further strengthen its position in the live cell encapsulation market. In line with this, the company commercialized pluripotent cells for research, drug discovery, and regenerative medicine therapies. It also focuses on inorganic growth strategies such as distribution agreements to maintain its market position.

Reed Pacific Pty Ltd (Australia) held the second-largest share of the live cell encapsulation market in 2017. The company distributes its live cell encapsulation products across Americas, Europe, and Asia. To strengthen its current position and gain a larger share of the live cell encapsulation market, the company mainly focuses on research activities and innovations in cell encapsulation field.

Related Reports:

Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Report Code
BT 7006
Published ON
Apr, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Live Cell Encapsulation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved